ANTONELLI, ANTONELLA
 Distribuzione geografica
Continente #
NA - Nord America 8.575
EU - Europa 5.438
AS - Asia 3.854
SA - Sud America 450
AF - Africa 66
OC - Oceania 21
Continente sconosciuto - Info sul continente non disponibili 19
AN - Antartide 1
Totale 18.424
Nazione #
US - Stati Uniti d'America 8.461
GB - Regno Unito 1.849
CN - Cina 1.804
SG - Singapore 1.160
UA - Ucraina 795
IT - Italia 622
RU - Federazione Russa 480
SE - Svezia 444
FI - Finlandia 348
BR - Brasile 344
TR - Turchia 326
DE - Germania 321
VN - Vietnam 209
FR - Francia 193
IE - Irlanda 193
IN - India 83
JP - Giappone 63
CA - Canada 61
PL - Polonia 49
BE - Belgio 42
MX - Messico 41
AR - Argentina 40
BD - Bangladesh 34
KR - Corea 27
IQ - Iraq 24
NL - Olanda 22
ZA - Sudafrica 22
IR - Iran 21
HK - Hong Kong 20
AU - Australia 19
EU - Europa 15
CL - Cile 14
EC - Ecuador 14
ES - Italia 14
MA - Marocco 13
RO - Romania 13
ID - Indonesia 12
LT - Lituania 12
AT - Austria 10
TG - Togo 10
PK - Pakistan 9
SA - Arabia Saudita 9
PY - Paraguay 8
VE - Venezuela 8
AZ - Azerbaigian 7
CO - Colombia 7
IL - Israele 6
JO - Giordania 5
KE - Kenya 5
LA - Repubblica Popolare Democratica del Laos 5
PE - Perù 5
TW - Taiwan 5
A2 - ???statistics.table.value.countryCode.A2??? 4
AE - Emirati Arabi Uniti 4
BO - Bolivia 4
CR - Costa Rica 4
DZ - Algeria 4
JM - Giamaica 4
KZ - Kazakistan 4
NO - Norvegia 4
PH - Filippine 4
SK - Slovacchia (Repubblica Slovacca) 4
BG - Bulgaria 3
MD - Moldavia 3
NG - Nigeria 3
PT - Portogallo 3
UY - Uruguay 3
UZ - Uzbekistan 3
AL - Albania 2
CG - Congo 2
CZ - Repubblica Ceca 2
EE - Estonia 2
EG - Egitto 2
GY - Guiana 2
HN - Honduras 2
NZ - Nuova Zelanda 2
OM - Oman 2
TN - Tunisia 2
AM - Armenia 1
AQ - Antartide 1
BJ - Benin 1
CH - Svizzera 1
CI - Costa d'Avorio 1
CY - Cipro 1
DK - Danimarca 1
DO - Repubblica Dominicana 1
ET - Etiopia 1
FK - Isole Falkland (Malvinas) 1
GE - Georgia 1
HR - Croazia 1
HU - Ungheria 1
IS - Islanda 1
KG - Kirghizistan 1
LK - Sri Lanka 1
LV - Lettonia 1
MY - Malesia 1
NP - Nepal 1
QA - Qatar 1
RS - Serbia 1
SI - Slovenia 1
Totale 18.423
Città #
Southend 1.688
Fairfield 867
Ashburn 799
Woodbridge 786
Jacksonville 632
Houston 604
Singapore 508
Ann Arbor 493
Chandler 473
San Jose 394
Nanjing 380
Cambridge 368
Seattle 345
Wilmington 333
Izmir 237
Dallas 234
Urbino 224
Beijing 220
Dublin 189
Boardman 178
Nanchang 157
Helsinki 155
New York 137
Los Angeles 127
Lauterbourg 120
Princeton 103
San Mateo 94
Changsha 77
Moscow 74
Bremen 67
Ho Chi Minh City 65
Hebei 63
Tianjin 62
Shenyang 60
Buffalo 57
Munich 55
Düsseldorf 53
Hanoi 48
Istanbul 43
Kunming 43
Jiaxing 42
Brussels 41
Santa Clara 41
Shanghai 40
Guangzhou 33
São Paulo 33
Jinan 30
London 30
Orem 29
San Diego 28
Tokyo 27
Velikiy Novgorod 27
Frankfurt am Main 26
The Dalles 26
Toronto 25
Warsaw 25
Hangzhou 24
Turku 23
Zhengzhou 23
Council Bluffs 22
Stockholm 21
Chicago 19
San Francisco 19
Brooklyn 18
Hong Kong 18
Rome 18
Chennai 17
Mülheim 17
Poplar 17
Atlanta 15
Denver 15
Mexico City 14
Mumbai 14
Ningbo 14
Rio de Janeiro 14
Boston 13
Kraków 13
Seongnam 13
Des Moines 12
Johannesburg 12
Lanzhou 12
Norwalk 12
Nuremberg 12
Shenzhen 12
Portsmouth 11
Seoul 11
Amsterdam 10
Ankara 10
Auburn Hills 10
Augusta 10
Da Nang 10
Leawood 10
Lomé 10
Montreal 10
Phoenix 10
Taizhou 10
Dhaka 9
Hamburg 9
Lappeenranta 9
Portland 9
Totale 12.726
Nome #
Interactions of Nitroxide-Conjugated and non-Conjugated Glycodendrimers with Normal and Cancer Cells and Biocompatibility Studies 307
Engineering erythrocytes for the modulation of drugs' and contrasting agents' pharmacokinetics and biodistribution 293
Dexamethasone restrains ongoing expression of interleukin-23p19 in peripheral blood-derived human macrophages. 281
2\',3\'-Dideoxycytidine cytotoxicity in human macrophages. 266
Effect of macrophage depletion on viral DNA rebound following antiretroviral therapy in a murine model of AIDS (MAIDS) 262
Improved cellular uptake of functionalized single-walled carbon nanotubes 260
Effect of the redox state on HIV-1 tat protein multimerization and cell internalization and trafficking 255
Red Blood Cell-Based Delivery of Drugs and Nanomaterials for Therapeutic and Diagnostic Applications 253
2',3'-Dideoxycytidine induced drug-resistance in human cells 251
Macrophage Depletion by Free Bisphosphonates and Zoledronate-Loaded Red Blood Cells 251
Erythrocyte-based drug delivery 250
Drug delivery through phagocytosis of red blood cells 247
Intracellular distribution of hexokinase in rabbit brain 246
Effect of the redox state on HIV-1 tat protein multimerization and cell internalization and trafficking 243
Characterization of ferucarbotran-loaded RBCs as long circulating magnetic contrast agents 237
Programmable 3D silk bone marrow niche for platelet generation ex vivo and modeling of megakaryopoiesis pathologies 230
Efficient inhibition of macrophage TNF-alpha production upon targeted delivery of K48R ubiquitin 226
Macrophage depletion induced by clodronate-loaded erythrocytes. 217
Encapsulation of superparamagnetic nanoparticles into red blood cells as new carriers of MRI contrast agents 216
Human erythrocytes as nanoparticle carriers for Magnetic Particle Imaging 211
New strategies to prolong the in vivo life span of iron-based contrast agents for MRI 207
Red blood cells as glucocorticoids delivery system. 205
New biomimetic constructs for improved in vivo circulation of superparamagnetic nanoparticles 204
Delivery of Contrasting Agents for Magnetic Resonance Imaging 204
Dexamethasone restrains ongoing expression of interleukin-23p19 in periferal blood-derived human macrophages. 203
The ubiquitin-dependent proteolytic system and other potential targets for the modulation of nuclear factor-kB (NF-kB) 201
SPIO nanoparticles encapsulation into human erythrocytes for MPI application 200
A Relaxometric Study of USPIO-loaded Red Blood Cells as MRI Contrast Agents 199
Intravascular contrast agents in diagnostic applications: Use of red blood cells to improve the lifespan and efficacy of blood pool contrast agents 198
Macrophage protection by nucleoside and nucleotide analogue administration 192
SPIO NANOPARTICLES ENCAPSULATION INTO HUMAN ERYTHROCYTES FOR MPI APPLICATION 191
Erythrocyte-based drug delivery 189
USPIO-loaded Red Blood Cells as a biomimetic MR contrast agent: a relaxometric study 187
Characterization and biological activity of the main flavonoids from Swiss Chard (Beta vulgaris subspecies cycla) 185
Modulation of ICAM-1 expression in ECV304 cells by macrophage-released cytokines 185
Erythrocyte-mediated delivery of drugs, peptides and modified oligonucleotides 184
Red blood cell phagocytosis following hexokinase inactivation. 184
A proteomic approach to identify ubiquitinated proteins in a macrophage cell-free system 183
Red blood cells as carriers in magnetic particle imaging 183
Effect of macrophage depletion on viral DNA rebound following antiretroviral therapy in a murine model of AIDS 182
Red blood cells as a glucocorticoids delivery system 180
Development of long circulating magnetic particle imaging tracers: use of novel magnetic nanoparticles and entrapment into human erythrocytes 179
Increased microbicidal activity of human monoblastoid cells upon long-term exposure to dideoxycytidine 178
The soluble but not mitochondrially bound hexokinase is a substrate for the ATP- and ubiquitin-dependent proteolytic system 178
Drug-loaded red blood cells for the control of the inflammatory response: selective targeting of nuclear factor-kB (NF-kB) 177
Encapsulation of new ferucarbotran nanoparticles into red blood cells as potential MPI contrast agent 177
Targeting dexamethasone to macrophages. 175
In vivo survival and in vitro phagocytosis of engineered erythrocytes. 174
Nanoparticle encapsulation in red blood cells enables blood-pool magnetic particle imaging hours after injection 171
Macrophage uptake of SWNT-COOC18H37 derivatives coated by phosphatidylethanolamine or phosphatidylserine 170
Modulation of NF-kB activation by targeted delivery of dexamethasone to macrophages 169
Bone marrow modeling for blood cell production 167
Macrophage protection by nucleoside and nucleotide analogue administration 166
Molecular basis of the 2',3'-dideoxycytidine induced drug-resistance in human cells 160
Red Blood Cells as Magnetic Carriers for MPI Applications 157
Use of Red Blood Cells as New Strategy to Avoid the Rapid Clearance of SPIOs Nanoparticles 157
Macrophage depletion by Clodronate-loaded erythrocytes 157
Erythrocytes as vascular carriers of superparamagnetic nanoparticle contrast agents 156
Red Blood Cells as Carriers of Iron Oxide-Based Contrast Agents for Diagnostic Applications 156
Antiviral Properties of Flavonoids and Delivery Strategies 156
Single-Walled Carbon Nanotubes Functionalization for the Delivery of the Water Insoluble Anticancer Agent Indole-3-carbinol Cyclic Tetrameric Derivative CTet 155
Study on the in vivo survival of murine Ferucarbotran-loaded RBCs for their use as new MPI contrast agents 153
Hexokinase is not ubiquitaned when mitochondrial-bound 152
Magnetic Manipulation of Blood Conductivity with Superparamagnetic Iron Oxide-Labeled Erythrocytes 151
Recent advances in synthesis, characterization of hydroxyapatite/polyurethane composites and study of their biocompatible properties 148
New biomimetic constructs for improved in vivo circulation of superparamagnetic nanoparticles 148
Biological Activity of Phytocomplexes purified from Beta Vulgaris 148
Macrophages depletion induced by clodronate-loaded erythrocytes 147
Selective inhibition of NF-kB activation and TNF-alpha production in macrophages by red blood cell-mediated delivery of dexamethasone 146
Effect of the redox state on HIV-1 tat protein multimerization and cell internalization and trafficking 145
Ferucarbotran-loaded red blood cells as long circulating MRI contrast agents: first in vivo results in mice 144
Location of ubiquitin conjugates and ubiquitin-conjugating enzymes in rabbit brain 143
Magnetic red blood cells as new contrast agents for MRI applications 133
In vitro survival and in vitro phagocytosis of engineered erythrocytes. 131
In vivo nanotoxicology: experiences in NACBO project 131
Encapsulation of Magnetic Nanoparticles in Human Erythrocytes 131
11. RED BLOOD CELLS AS A GLUCOCORTICOIDS DELIVERY SYSTEM 130
Evidence for a particulate location of ubiquitin conjugates and ubiquitin-conjugating enzymes in rabbit brain. 125
Efficient inhibition of macrophage TNF-alpha production by red cell mediated drug targeting 125
Human Red Blood Cells Modulate Cytokine Expression in Monocytes/Macrophages Under Anoxic Conditions 125
Use of Red Blood Cells to prolong the in vivo life span of Iron-based contrast agents for MRI and MPI 124
Engineered Red Blood Cells for the delivery and targeting of corticosteroid analogues 121
Modulation of macrophage activation by red cell-mediated drug targeting 121
New biomimetic contructs for improved in vivo circulation of superparamagnetic nanoparticles. 121
Anoxia Rapidly Induces Changes in Expression of a Large and Diverse Set of Genes in Endothelial Cells 121
Programmed cell death in 2',3'-dideoxycytidine-resistant human monoblastoid U937 cells. 120
The influence of redox modulation on hypoxic endothelial cell metabolic and proteomic profiles through a small thiol-based compound tuning glutathione and thioredoxin systems 119
Modulation of the macrophage function in the hematopoietic niche by using engineered RBCs 119
Evaluation of magnetization response of superparamagnetic nanoparticles loaded RBCs 118
New biomimetic constructs to prolong in vivo the life span of iron-based MRI/MPI contrasting agents 118
Specific targeting of antisense PNA by erythrocytes for the inhibition of nitric oxide production in murine macrophages 117
Encapsulation in human and murine erythrocytes of the Synomag®-D-PEG-OMe tracer for MPI application 116
In vivo survival and in vitro phagocytosis of engeneered erythrocytes 115
Red Blood Cells Constructs to Prolong the Life Span of Iron-Based Magnetic Resonance Imaging/Magnetic Particle Imaging Contrast Agents In Vivo 114
Characterization of the Synomag®-D-PEG-OMe nanoparticles for the encapsulation in human and murine red blood cells 112
Red blood cells for improved in vivo circulation of SPIO nanoparticles MRI contrast agents 110
Encapsulation of new MPI tracer nanoparticles in the human red blood cells 103
Antioxidant, Anti-Inflammatory, Anti-Diabetic, and Pro-Osteogenic Activities of Polyphenols for the Treatment of Two Different Chronic Diseases: Type 2 Diabetes Mellitus and Osteoporosis 99
Inhibition of nitric oxide production in murine macrophages by specific targeting of antisense PNA loaded erythrocytes 99
Encapsulation of new MPI tracer nanoparticles in the human red blood cells 96
Totale 17.322
Categoria #
all - tutte 64.869
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 64.869


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021515 0 0 0 0 0 0 0 0 0 168 266 81
2021/20221.077 71 88 126 124 41 47 93 70 66 84 23 244
2022/20231.603 204 88 29 160 182 340 3 86 316 59 84 52
2023/2024451 49 36 32 60 45 105 12 20 7 38 5 42
2024/20251.959 96 70 345 151 76 130 219 97 252 158 207 158
2025/20264.042 404 393 487 838 438 291 512 135 294 250 0 0
Totale 18.629